PubMed Health⌕ Search

Biomedical subjects

H Wolf

Publications and source records attributed to H Wolf.

At least 685 records · Page 38Linked to original sources
PubMed1977

Compensatory renal hypertrophia in patients undergoing unilateral nephrectomy.

Estimations of the residual glomerular filtration rate (GFR) were made from renography and GFR measurements before unilateral nephrectomy in 28 patients aged 42-77 years. The GFR was measured one week and three months after the operation and comparisons were made between the function of the remaining kidney and the preoperative estimate. In 23 patients where the removed kidney had some function, the mean GFR increased by 32% and 22% after one week and three months, respectively. In 5 patients where the removed kidney had no function, no compensatory hypertrophy occurred.

Adaptation, Physiological↗
PubMed1977

[Easy alteration of the PEEP-system to CPAP by using exclusively original bird parts (author's transl)].

In various situations breathing with positive-end expiratory pressure (PEEP) and spontaneous respiration with continously positive airway pressure (CPAP) is of advantage to the patient. Not all intensive care units are equipped with the modern apparatus that makes possible alternative application of PEEP and CPAP. We have developed a system using a BIRD Mark 7 or 8 that allows alteration of PEEP to CPAP by only few manipulations. As a safety measure we exclusively apply original parts of the same firm (BIRD). The system allows exact adjustment and controllable application of a continuous positive airway pressure, exact proportion of oxygen in the inspired gas, moistening of the in spired air and nebulization of medicaments. If the patient should show inadequate ventitation after a certain times then artificial respiration with the PEEP system is quickly possible with only a few manipulations.

Humans↗
PubMed1976

[Investigations on the utilization of parenterally administered amino acids in premature and small-for-dates neonates. IV. Control of the amino acid blood level during infusion of a pharmacokinetically balanced amino acid solution (author's transl)].

An amino acid solution composed according to pharmacokinetic criteria was infused in 12 premature and 4 full-term infants. Imbalances of amino acids were not observed when the upper limit of the fasting level was accepted as a measure for balance or imbalance. The net transfer of total amino acids increased by about 40% over that in former experiments (second communication (4)). A decrease of cystine, a semiessential amino acid, could be avoided. The results were compared with the literature. During infusion, the urinary excretion of amino acids was not increased showing nearly complete utilization of the infused amin acids.

Amino Acids↗
PubMed1976

[Investigations on the utilization of parenterally administered amino acids by premature and hypotrophic neonates (author's transl)].

The composition of an amino acid solution for intravenous use in newborns is discussed in the light of the metabolic kinetics of its constituents. Such a solution would be optimal when based on the transfer characteristics of the single amino acids used. Under these circumstances one would avoid imbalances in the respective blood levels. In particular, the average amount of such a solution needed, and the maximal turnover rates per hour of the specific amino acids during the first 4 weeks of life are discussed.

Amino Acids↗
PubMed1976

[Q-Fever and its complications (author's transl)].

Q-Fever recurs as localized epidemics in the German Federal Republic. The disease has not previously been observed in North Hesse. During a familial infection with Coxiella burneti a 15-year-old boy together with his parents and an aunt became ill with atypical pneumonia. After the pulmonary symptoms had subsided a deep left leg and pelvic venous thrombosis occurred in the boy in the fifth week after the onset of the disease. The thrombosis which is very rare in childhood could be successfully removed at operation.

Adolescent↗
PubMed1976

Residual kidney function after unilateral nephrectomy. Pre- and postoperative estimation by renography and clearance measurements.

The residual kidney function was predicted from preoperative renography and determination of the glomerular filtration rate (GFR) in 57 patients undergoing unilateral nephrectomy for cancer, postrenal obstruction or renovascular hypertension. Postoperative GFR measurements were carried out 6-36 months after the operation. In eleven patients where the kidney removed had no function, no significant difference was found between pre- and postoperative GFR values. In 46 patients where the kidney removed had some function, the preoperative estimate was a little too high in only two patients. In this group, the postoperative GFR on an average amounted to 42% above the preoperatively predicted value. We conclude that the combination of 51Cr-EDTA clearance and renography is a reliable, non-invasive method for determination of the minimum residual kidney function before unilateral nephrectomy is carried out.

Adult↗
PubMed1976

Transcutaneous PO2 monitoring in routine management of infants and children with cardiorespiratory problems.

Results are reported concerning the clinical application of the transcutaneous PO2 method (tc PO2 method) according to Huch et al. for monitoring arterial PO2. Thirty long-term continuous tc PO2 recordings were made in 22 ventilated children and infants with cardiorespiratory problems in four different pediatric intensive care units (Zürich, Göttingen, Kassel, and Mainz). These recordings were compared with 132 arterial PO2 determinations made during the same period of time. There was a linear relationship and a close correspondence between arterial PO2 and tc PO2 (r = .94). The continuous recordings have shown that the variability of PO2 is much greater than assumed so far by single blood gas analysis. This fact restricts greatly the value of single samples. Continuous tc PO2 monitoring has proved to be a great help in optimal respirator setting.

Child↗
PubMed1976

[Rapid intravenous injection of streptokinase in a high initial dose for therapy of a fulminant pulmonary embolism (author's transl)].

As a result of the case described the administration of streptokinase in a high initial dosage of about 750,000-1,000,000 U within a few minutes appears to be effective in serious lethal pulmonary embolism. In spite of hypoxic cardiac arrest a 35-year-old female patient was reanimated successfully 20 minutes after the occurrence of pulmonary embolism on the 10th day after caesarian section. The development indicated that the high dosage of streptokinase led to lysis of the embolus and thus to perfusion of the lungs. In spite of complications haemothorax 4,000 ml, uterine haemorrhage the fibrinolytic and later the anticoagulante therapy was continued until lysis of the embolus was assumed as judged by the condition of the patient. To prevent a renewed cardiac arrest a temporary pacemaker was applied. The patient survived without evidence of a cerebral lesion. This paper wants to advocate the administration of streptokinase in "exorbitant" dosage in hopeless cases of serious pulmonary embolism of which a high percentage die. It is essential that the injection be made within a few minutes and must not be extended over the normally recommended period of time.

Adult↗
PubMed1976

Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.

The simultaneous 24 hours excretion of pseudouridine and beta-aminoisobutyric acid in the urine from patients treated for low grade urothelial tumours has been determined and related to tumour recurrence inside of 6 months after the determinations. The results of 53 assays in 39 patients without clinical signs of recurrence at the time of the detrmination showed a high excretion of pseudouridine in 53% and of beta-aminoisobutyric acid in 28.5% of the assays. Recurrences appeared more often after a high urinary pseudouridine (53.5%) than after a low, but the difference was not statistically significant (p more than 0.05) and more often after a low urinary beta-aminoisobutyric acid (52.5%) than after a high (p less than 0.01). The highest incidence of recurrence was in patients with a simultaneously high urinary pseudouridine and a low urinary beta-aminoisobutyric acid. Seventy per cent of these excretion patterns were from patients, who developed a recurrence before 6 months (p less than 0.002).

Adult↗
PubMed1976

[Kleinschmidt's syndrome (author's transl)].

This is a case-report about a 4 year old boy with "cherry red" epiglottis, purulent meningitis and pleuropneumonia. Purulent meningitis and pleuropneumonia are not complications of treatment of "cherry red" epiglottis but an entity caused by Hemophilus influenzae-infection and is called Kleinschmidt's syndrome (Hemophilus influenzae type B-infection-syndrome). This severe illness is successfully treated if recognized early enough. At present, chloramphenicol is the therapy of choice. Intubation or tracheotomy are important but supportive measures.

Child, Preschool↗
PubMed1975

[Investigations on the utilisation of parenterally administered amino acids by premature and small-for-dates neonates. II. Investigations of elimination half life time, elimination constants, transfer and clearances of amino acids after short-time infusion of L-amino acid mixtures (author's transl)].

10 ml/kg body weight of a 5% standardized L-amino-acid-mixture was given within the first 25 days to 25 prematurely born infants of 32--37 weeks gestationale and 5 small-for-dates newborns. We studied the metabolic kinetics of these amino acids in the serum and calculated elimination half life time, elimination constants, clearance and transfer rates of the single amino acids. The results were correlated with sex, nutritional state and age. 5 additional experiments were performed with 3 prematurely born infants and 2 small-for-dates newborns. The following results were of special interests: 1. Nearly all amino-acids had half life times between 30 and 50 min. Ornithine and tryptophane were more (half life time: 70 and about 50 min, respectively) slowly eliminated, while arginine and glutamic acid had half life times of between 5 and 15 min. 2. There was no statistically significant differences between sexes. 3. Eutrophic prematures eliminated the amino acids much faster then the hypotrophic ones. 4. Hypotrophic premature infants showed slow elimination of nearly all amino acids compared with hypotrophic newborns. 5. The elimination of nearly all amino acids studied grew faster with increasing age. The most significant differences were registered between the 1st and 3rd weeks of life.

Age Factors↗
PubMed1975

[Investigations on the utilization of parenterally administered amino acids by premature and small-for-dates neonates. I. Free amino acids in the blood of premature and small-for dates neonates (author's transl)].

The fasting levels of free amino acids were determined in the serum of 23 premature and 7 small-for-dates newborns during the first 4 weeks of life. This was done by ion-exchange chromatography after ultrafiltration of the serum, which allowed quantification. Differences were recognized in regards to age, and nutritional state: 1. Small-for-dates newborns at term showed significantly lower asparagine and glycine levels when compared to hypotrophic prematures. 2. Leucine was lower in male than in female prematures. 3. Leucine and phenylalanine were lower in hypotrophic than in eutrophic prematures. 4. Nearly all investigated fasting amino acid levels were highest in the 3rd week of life. A decrease was observed during the 4th week of life. Threonine, Proline, Alanine, Valine, Isoleucine, Lysine and Arginine were significantly higher in the 3rd compared to the 1st week.

Age Factors↗
PubMed1975

Lymphoproliferative disease in a cotton-top marmoset after inoculation with infectious mononucleosis-derived Epstein-Barr virus.

Injection of concentrated EBV derived from cells of the Kaplan line of infectious mononucleosis (IM) origin resulted in malignant lymphoproliferation in one out of three cotton-top marmosets 6 weeks after inoculation. Two additional animals receiving the same isolate after incubation with an antibody-containing human serum did not develop tumors. Inoculation of concentrated virus derived from the P3HR-1 line of Burkitt origin did not lead to lymphoproliferations in five marmosets. Three of these received non-neutralized, and two received neutralized P3HR-1 virus. The tumor obtained with the Kaplan isolate revealed characteristics of a lymphosarcome. It contained EBV-specific DNA. In addition, EBV-synthesizing lymphoblastoid lines were established from a tumorous lymph-node, as well as from the spleen of the diseased marmoset. Virus recovered from these lines transformed lymphocytes derived from spleens of healthy marmosets. The tumor-bearing animal developed low levels of anti-VCA antibodies during the course of tumor growth. These data demonstrate the oncogenic potential of EBV directly derived from cells of IM origin.

Animals↗